article thumbnail

Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes

Express Pharma

It is a treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors. Mounjaro is also indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. per cent and 2.1

article thumbnail

What will shape the Pharma landscape in Q3 2025?

European Pharmaceutical Review

In 2021, the FDA first approved the long-acting somatropin prodrug for children aged one year and over with paediatric growth hormone deficiency (GHD) who weigh at least 25.4 Clinical data for diabetes supports the drug’s potential as an obesity medicine, stated GlobalData.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Tranq dope (fentanyl-xylazine combination): A new horizon in opioid withdrawal treatment

ALiEM - Pharm Pearls

Last Words Substance use disorders (SUD) are similar to other chronic relapsing medical conditions such as diabetes mellitus, congestive heart failure/cardiomyopathy, chronic obstructive pulmonary disorder, and cancer. 2021 Aug 1;94:103086. I am happy to help how I can. References Reuter P, Pardo B, Taylor J. 2023 Jan 1;53(1):140-2.

article thumbnail

Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData

Express Pharma

Eli Lilly and Co’s orforglipron is emerging as a promising oral glucagon-like peptide (GLP)-1 therapy, with upcoming clinical milestones in obesity and diabetes set to shape its market trajectory. Eli Lilly’s orforglipron is also being investigated as a treatment for diabetes and weight loss, obstructive sleep apnea, and hypertension.

article thumbnail

Therapeutic Guidelines, Australian Medicines Handbook and APF

RX Note

External Links APF and Handbook 25th Edition, 2021 Therapeutic Guidelines FAQ Currently, a single, consolidated national drug formulary encompassing all drugs legally available for use across both public and private sectors does not exist in Malaysia.

article thumbnail

Carefully Monitor Direct Oral Anticoagulant Medications

Pharmacy Times

Updated August 15, 2021. Janssen Pharmaceuticals, Inc; 2021. Updated June 15, 2020. Accessed June 4, 2025. link] Apixaban. MedlinePlus. Updated February 15, 2025. Accessed June 4, 2025. link] Dabigatran. MedlinePlus. Accessed June 4, 2025. link] Chen A, Stecker E, Warden BA. J Am Heart Assoc. 2020;9(13):e017559. doi:10.1161/JAHA.120.017559